title: Challenges to pediatric HIV care and treatment in South Africa.
abstract: It is estimated that almost 300,000 children in South Africa have human immunodeficiency virus (HIV) infection. The disease is responsible for reversing decreases in child mortality. Few data exist evaluating the outcomes of the prevention of mother-to-child transmission of HIV (PMTCT) program, although PMTCT coverage appears to be low. Hospitals are still witnessing large numbers of admissions of HIV-infected children. Postnatal transmission of HIV is high, reflecting poor education of and support for women in their infant feeding choices. Too few infants and children are entering care through early diagnosis, which should be widely available. Cotrimoxazole prophylaxis coverage is inadequate, contributing to high morbidity and mortality in infants. The number of children receiving antiretroviral therapy (ART) is increasing steadily. However, significant inequalities in access to ART exist between and within provinces. Challenges for pediatric ART include a lack of sufficiently trained health care personnel and inadequate facilities, as well as the complexity of drug regimens and formulations. The compartmentalization of the ART rollout program hinders PMTCT and makes it difficult for children to be identified and referred into appropriate services. This article delineates the challenges to pediatric HIV care in South Africa and provides some practical recommendations to improve it.
authors.affiliation: Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, Johannesburg, South Africa. tammy@meyers.net
authors.forename: Tammy
authors.initials: T
authors.lastname: Meyers
authors.forename: Harry
authors.initials: H
authors.lastname: Moultrie
authors.forename: Kimesh
authors.initials: K
authors.lastname: Naidoo
authors.forename: Mark
authors.initials: M
authors.lastname: Cotton
authors.forename: Brian
authors.initials: B
authors.lastname: Eley
authors.forename: Gayle
authors.initials: G
authors.lastname: Sherman
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D002648:Child; D005260:Female; D006678:HIV / Q000302:isolation & purification*; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000635:transmission / Q000821:virology; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D010372:Pediatrics / Q000379:methods; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology; D013019:South Africa / Q000453:epidemiology